Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Non-cash Items: 2012-2025

Historic Non-cash Items for Abeona Therapeutics (ABEO) over the last 2 years, with Sep 2025 value amounting to $174,792.

  • Abeona Therapeutics' Non-cash Items rose 2084.90% to $174,792 in Q3 2025 from the same period last year, while for Sep 2025 it was $174,792, marking a year-over-year increase of 2084.90%. This contributed to the annual value of $6,000 for FY2024, which is 100.00% up from last year.
  • Per Abeona Therapeutics' latest filing, its Non-cash Items stood at $174,792 for Q3 2025, which was up 2,813.20% from $6,000 recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Non-cash Items ranged from a high of $174,792 in Q3 2025 and a low of $1,000 during Q2 2024.
  • In the last 3 years, Abeona Therapeutics' Non-cash Items had a median value of $6,000 in 2025 and averaged $43,212.
  • Within the past 5 years, the most significant YoY rise in Abeona Therapeutics' Non-cash Items was 2,084.90% (2025), while the steepest drop was 97.92% (2025).
  • Over the past 3 years, Abeona Therapeutics' Non-cash Items (Quarterly) stood at $3,000 in 2023, then soared by 100.00% to $6,000 in 2024, then soared by 2,084.90% to $174,792 in 2025.
  • Its Non-cash Items was $174,792 in Q3 2025, compared to $6,000 in Q2 2025 and $3,000 in Q1 2025.